Skip to main content
SpringerLink
Log in

Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein (a) levels

  • Articles
  • Published:
Lipids

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Most studies on the topic have shown that statin therapy decreases plasma LDL levels but not those of lipoprotein(a) [Lp(a)]. This specificity of action, although previously noted, has not been systematically investigated. In the current study we approached this problem by monitoring LDL- and Lp(a) cholesterol in 80 hypercholesterolemic subjects with high Lp(a) levels, at entry and 8 mon after initiation of statin therapy. We found that commonly used direct and indirect LDL cholesterol assays gave an LDL cholesterol value that comprised both true LDL- and Lp(a) cholesterol. We estimated these two analytes from the values of Lp(a) protein determined by FLISA and from knowledge of the Lp(a) chemical composition, complemented by data from immunochemical and ultracentrifugal analyses. Statin therapy, while not affecting plasma Lp(a) protein levels (21.7±10.4, before, and 22.0±10.1 mg/dL, after), caused a decrease in the estimated or true LDL cholesterol (P<0.0001) to values in some cases as low as 10 mg/dL. This drop in true LDL was validated by the decrease in the LDL band in the ultracentrifugation profiles, and its magnitude was proportional to the degree of total cholesterol lowering and to the pretreatment true LDL/Lp(a) cholesterol weight ratio. We conclude that true LDL but not Lp(a) cholesterol is affected by statin therapy and that this specific response cannot be monitored by current LDL cholesterol assays and must, rather, rely on estimates of these two analytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

apo(a):

apolipoprotein(a)

apoB:

apolipoprotein B

apoA-I:

apolipoprotein A-I

CK:

creatine kinase

est-LDL:

estimated LDL cholesterol as determined by subtracting Lp(a) cholesterol from total LDL cholesterol

Lp(a):

lipoprotein(a)

References

  1. Scanu, A.M., Nakajima, K., and Edelstein, C. (2001) Apolipoprotein(a): Structure and Biology, Front. Biosci. 6, 546–554.

    Google Scholar 

  2. Scanu, A.M., and Fless, G.M. (1990) Lipoprotein (a): Heterogeneity and Biological Relevance, J. Clin. Invest. 85, 1709–1715.

    PubMed  CAS  Google Scholar 

  3. Utermann, G. (1995) Lipoprotein (a), in The Metabolic and Molecular Basis of Inherited Disease (Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D., eds.), pp. 1887–1912, McGraw-Hill, New York.

    Google Scholar 

  4. Lawn, M.R., and Scanu, A.M. (1996) Lipoprotein(a), in Atherosclerosis and Coronary Artery Disease (Fuster, V., Ross, R., and Topol, E.J., eds.), pp. 151–161, Lippincott-Raven, Philadelphia.

    Google Scholar 

  5. Scanu, A.M. (2001) Lipoprotein(a), Friedewald Formula and NCEP Guidelines, National Cholesterol Education Program, Am. J. Cardiol. 87, 608–609.

    Article  PubMed  CAS  Google Scholar 

  6. Bachorik, P.S. (1997) Measurement of Low-Density-Lipoprotein Cholesterol, in Handbook of Lipoprotein Testing (Rifai N., Warnick, E.R., and Dominiczak, M.H., eds.), pp. 235–243, AAAC Press, Washington, DC.

    Google Scholar 

  7. Friedewald, W.T., Levy, R.I., and Fredrickson, D.S. (1972) Estimation of the Distribution of Low Density Lipoprotein Cholesterol in Plasma Without the Use of the Preparative Centrifuge, Clin. Chem. 18, 499–502.

    PubMed  CAS  Google Scholar 

  8. Edelstein, C., and Scanu, A.M. (1986) Precautionary Measure for Collecting Blood Destined for Lipoprotein Isolation, Methods Enzymol. 128, 151–155.

    Article  PubMed  CAS  Google Scholar 

  9. Fless, G.M., Snyder, M.L., and Scanu, A.M. (1989) Enzyme-Linked Immunoassay for Lp(a), J. Lipid Res 30, 651–662.

    PubMed  CAS  Google Scholar 

  10. Fless, G.M., Zummallen, M.E., and Scanu, A.M. (1987) Heterogeneity of Human Plasma Lp(a), in Proceedings of the Workshop on Lipoprotein Heterogeneity (Lippel, K., ed.), pp. 141–153, NIH Publication No. 87-2646, NIH, Bethesda.

    Google Scholar 

  11. Fless, G.M., Rolih, C.A., and Scanu, A.M. (1984) Heterogeneity of Human Plasma Lp(a): Isolation and Characterization of the Lipoprotein Subspecies and Their Apoproteins, J. Biol. Chem. 259, 11470–11478.

    PubMed  CAS  Google Scholar 

  12. Lackner, C., Boerwinkle, E., Leffert, C.C., Rahmig, T., and Hobbs, H.H. (1991) Molecular Basis of Apolipoprotein(a) Isoform Size Heterogeneity as Revealed by Pulsed-Field Gel Electrophoresis, J. Clin. Invest. 87, 2153–2161.

    PubMed  CAS  Google Scholar 

  13. Hixson, J.E., and Vernier, D.T. (1990) Restriction Isotyping of Human Apolipoprotein E by Gene Amplification and Cleavage with Hhal, J. Lipid Res. 31, 545–548.

    PubMed  CAS  Google Scholar 

  14. Nakajima, K., Hinman, J., Pfaffinger, D., Edelstein, C., and Scanu, A.M. (2001) Changes in Plasma Triglyceride Levels Shift Lipoprotein(a) Density in Parallel with That of Low-Density Lipoprotein Independently of Apolipoprotein(a) Size, Arterioscler. Thromb. Vasc. Biol. 21, 1238–1243.

    PubMed  CAS  Google Scholar 

  15. Nilsson, J., Mannickarottu, V., Edelstein, C., and Scanu, A.M. (1981) An Improved Detection System Applied to the Study of Serum Lipoproteins After Single-Step Density Gradient Ultracentrifugation, Anal. Biochem. 110, 342–348.

    Article  PubMed  CAS  Google Scholar 

  16. Edelstein, C., Italia, J.A., Klezovitch, O., and Scanu, A.M. (1996) Functional and Metabolic Differences Between Elastase-Generated Fragments of Human Lipoprotein(a) and Apolipoprotein(a), J. Lipid Res. 37, 1786–1801.

    PubMed  CAS  Google Scholar 

  17. Seman, L.J., Jenner, J.L., McNamara, J.R., and Schaefer, E.J. (1994) Quantification of Lipoprotein(a) in Plasma by Assaying Cholesterol in Lectin-Bound Plasma Fraction, Clin. Chem. 40, 400–403.

    PubMed  CAS  Google Scholar 

  18. Maher, V.M.G., and Brown, B.G. (1995) Lipoprotein(a) and Coronary Heart Disease, Curr. Opin. Lipid. 6, 229–235.

    Article  CAS  Google Scholar 

  19. Kane, J.P., and Havel, R.J. (1995) Disorders of the Biogenesis and Secretion of Lipoproteins Containing the B Apolipoproteins, in Metabolic and Molecular Basis of Inherited Disease (Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D., eds.), pp. 1853–1885, McGraw-Hill, New York.

    Google Scholar 

  20. Brown, S.L. (1996) Lowered Serum Cholesterol and Low Mood, Br. Med. J. 313, 637–638.

    CAS  Google Scholar 

  21. Lindberg, G., Larsson, G., Setterlind, S., and Rastam, L., (1994) Serum Lipid and Mood in Working Men and Women in Sweden, J. Epidemiol. Commun. Health 48, 360–363.

    CAS  Google Scholar 

  22. Partonen, T., Haukka, J., Virtamo, J., Taylor, P.R., and Lonngvist, J. (1999) Association of Low Serum Total Cholesterol with Major Depression and Suicide, Br. J. Psychiatry 175, 259–262.

    Article  PubMed  CAS  Google Scholar 

  23. Manfredini, R., Caracciolo, S., Salmi, R., Boari, B., Tomelli, A., and Gallerani, M. (2000) The Association of Low Serum Cholesterol with Suicidal Behaviours: New Hypotheses for the Missing Link, J. Int. Med. Res. 28, 247–257.

    PubMed  CAS  Google Scholar 

  24. Ellison, L.F., and Morrison, H.I. (2001) Low Serum Cholesterol and Risk of Suicide, Epidemiology 12, 169–172.

    Google Scholar 

  25. Alvarez, J.-C., Cremniter, D., Gluck, N., Quintin, P., Leboyer, N., Berlin, I., Therond, P., and Spreux-Varoquax, O. (2000) Low Serum Cholesterol in Violent but Not in Non-violent Suicide Attempters, Psychiatry Res. 95, 103–108.

    Article  PubMed  CAS  Google Scholar 

  26. Golomb, B.A., Stattin, H., and Mednick, S. (2000) Low Cholesterol and Violent Crime, J. Psychoatr. Res 34, 301–309.

    Article  CAS  Google Scholar 

  27. Executive Summary of the Third Report of the National Cholesterol Education Program (NECP) (2001) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA 285, 2486–2497.

  28. Frost, P.H., and Havel, R.J. (1998) Rationale for Use of Non-High-Density Lipoprotein Cholesterol Rather Than Low-Density Lipoprotein Cholesterol as a Tool for Lipoprotein Cholesterol Screening and Assessment of Risk and Therapy, Am. J. Cardiol. 81, 26B-31B.

    Article  PubMed  CAS  Google Scholar 

  29. Cui, Y., Blumenthal, R.S., Flaws, J.A., Whiteman, M.K., Langenberg, P., Bachorik, P.S., and Bush, T.L. (2001) Non-high-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality, Arch. Intern. Med. 161, 1413–1419.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Chicago, 5841 S. Maryland Ave, MC5041, 60637, Chicago, Illinois

    Angelo M. Scanu & Janet Hinman

  2. Department of Biochemistry and Molecular Biology, University of Chicago, 5841 S. Maryland Ave, MC5041, 60637, Chicago, Illinois

    Angelo M. Scanu

Authors
  1. Angelo M. Scanu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janet Hinman
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Scanu, A.M., Hinman, J. Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein (a) levels. Lipids 37, 439–444 (2002). https://doi.org/10.1007/s11745-002-0915-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11745-002-0915-1

Keywords

Search

Navigation